In a separate case series, Belati et al. [62] provided insights into the use of MEM-VAB plus aztreonam to treat infections caused by CAZ-AVI-resistant Klebsiella pneumoniae (Kp), including two cases sustained by NDM-Kp. Here, NPPA is linked to infection.